Grant: Canada Research Chairs
University of Ottawa
$100,000.00
Chemical Biology
FY 2017-18
Summary
Minute changes in the molecular processes driving our cells signal the onset of disease, or its reversal through treatment, long before outward signs or symptoms. The non-invasive detection of these changes is possible through MRI or PET, however has not yet been realized due to a lack of available tracer chemistry capable of amplifying these molecular signals. To this end, a toolbox of tracer chemistry platforms engineered to amplify these minute molecular changes and applicable to a broad range of molecular targets for both MRI and PET imaging will be developed, with the potential for improving disease diagnosis and therapy.
Program
Canada Research Chairs
Recipient
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
NSERC's Awards Data
As published
Application id
1000230754-2014
Name nom
Shuhendler, Adam
Department département
Chemistry
Organization id
28
Institution établissement
University of Ottawa
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2017
Competition year année de concours
2014
Award amount
100000
Program id
CRC
Program name en
Canada Research Chairs
Program name fr
Chaires de recherche du Canada
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
9998
Committee name en
Canada Research Chair Selection Committee
Committee name fr
Comité de sélection des Chaires de recherche du Canada
Area of application code
9999
Area of application group en
Not available
Area of application group fr
Non disponible
Area of application en
Not available
Area of application fr
Non disponible
Research subject code
1900
Research subject group en
Biomedical engineering
Research subject group fr
Génie biomédical
Research subject en
Biomedical engineering
Research subject fr
Génie biomédical
Partie
0
Application title
Chemical Biology
Keyword
CRC
Application summary
Minute changes in the molecular processes driving our cells signal the onset of disease, or its reversal through treatment, long before outward signs or symptoms. The non-invasive detection of these changes is possible through MRI or PET, however has not yet been realized due to a lack of available tracer chemistry capable of amplifying these molecular signals. To this end, a toolbox of tracer chemistry platforms engineered to amplify these minute molecular changes and applicable to a broad range of molecular targets for both MRI and PET imaging will be developed, with the potential for improving disease diagnosis and therapy.